|
LUC7L3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.48900000002317E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.234900E-04 |
| Normal-vs-Stage2 |
1.022300E-02 |
| Normal-vs-Stage3 |
1.001750E-04 |
| Normal-vs-Stage4 |
1.657060E-03 |
| Stage1-vs-Stage2 |
5.017400E-01 |
| Stage1-vs-Stage3 |
1.943190E-01 |
| Stage1-vs-Stage4 |
4.636600E-01 |
| Stage2-vs-Stage3 |
7.434000E-01 |
| Stage2-vs-Stage4 |
9.703000E-01 |
| Stage3-vs-Stage4 |
6.708200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67566000000008E-05 |
| Normal-vs-AfricanAmerican |
1.971930E-04 |
| Normal-vs-Asian |
1.99300000003344E-06 |
| Caucasian-vs-AfricanAmerican |
4.144400E-02 |
| Caucasian-vs-Asian |
7.898000E-02 |
| AfricanAmerican-vs-Asian |
4.181600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.3170999999993E-05 |
| Normal-vs-Female |
1.73670000047643E-07 |
| Male-vs-Female |
7.861900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.326050E-01 |
| Normal-vs-Age(41-60Yrs) |
9.38120000015807E-07 |
| Normal-vs-Age(61-80Yrs) |
9.5837000000043E-05 |
| Normal-vs-Age(81-100Yrs) |
2.356400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.048200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.053000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.869800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.650400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.141600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.933200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.741300E-03 |
| Normal-vs-Grade 2 |
1.60209999999772E-06 |
| Normal-vs-Grade 3 |
3.591100E-04 |
| Normal-vs-Grade 4 |
7.000300E-03 |
| Grade 1-vs-Grade 2 |
1.205570E-01 |
| Grade 1-vs-Grade 3 |
5.454000E-02 |
| Grade 1-vs-Grade 4 |
7.518400E-02 |
| Grade 2-vs-Grade 3 |
3.177400E-01 |
| Grade 2-vs-Grade 4 |
5.629400E-01 |
| Grade 3-vs-Grade 4 |
8.843800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.99049999991286E-07 |
| Normal-vs-ccB subtype |
6.078000E-03 |
| ccA subtype-vs-ccB subtype |
8.865600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.19010000000108E-05 |
| Normal-vs-N1 |
1.655180E-01 |
| N0-vs-N1 |
9.244000E-01 |
|
|
